Status:
RECRUITING
Efficacy and Safety of Thermic Devices in the Treatment of Meibomian Gland Dysfunction
Lead Sponsor:
Universidad Autonoma de Nuevo Leon
Collaborating Sponsors:
Hospital Universitario Dr. Jose E. Gonzalez
Conditions:
Meibomian Gland Dysfunction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Dry eye syndrome is a common eye disease that affects 1 to 2 out of 10 persons around the planet. One common cause of this disease is the meibomian gland dysfunction. Meibomian glands are very small g...
Detailed Description
Dry eye syndrome is considered one of the most important ophthalmologic diseases, affecting 10 to 20% of the general population. Of these, 3.7% to 70% of cases are due to meibomian gland dysfunction (...
Eligibility Criteria
Inclusion
- Patients diagnosed with:
- Dry eye syndrome with meibomian gland dysfunction alone or in combination of other type of dry eye.
- Patients who were previously treated with eyelid massages and warm compresses without any improvement.
Exclusion
- Pregnant women.
- History of ocular surgery within three months prior to inclusion.
- History of trauma, infection or inflammation within three months prior to inclusion.
- Contact lens use in the last week before inclusion.
- Patients with active ocular allergic disease.
- Patient with microbial keratitis.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT03767530
Start Date
September 1 2019
End Date
December 1 2025
Last Update
April 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Departamento de Oftalmologia, Hospital Universitario "Dr. Jose Eleuterio Gonzalez"
Monterrey, Nuevo León, Mexico, 64460